BIO-Europe Spring® 2017: Partnerships are key for rare disease drug discovery and development

April 11, 2017

What kinds of partnerships are key to getting rare disease research out of the lab and to patients as therapies and cures? Wendy White, Board Chairman of Global Genes, discusses her work on behalf of the leading global rare disease patient advocacy organization, and the impact patient advocacy groups are making on rare disease research.

 


EBD Group is committed to the rare disease community. To further partnering and collaboration opportunities between leaders from patient advocacy groups, industry, academia and government, the inaugural Cell & Gene Exchange event will be held in Washington, DC May 22–23, 2017. 

Previous Video
BIO-Europe Spring® 2017: Newron CEO on Xadago and upcoming pipeline milestones
BIO-Europe Spring® 2017: Newron CEO on Xadago and upcoming pipeline milestones

Newron CEO Stefan Weber discusses the company's Parkinson's therapy, Xadago (safinamide), on the eve of its...

Next Video
BIO-Europe Spring® 2017: Atriva repurposes cancer drug candidates to create universal flu treatment
BIO-Europe Spring® 2017: Atriva repurposes cancer drug candidates to create universal flu treatment

Dr. Rainer Lichtenberger, CEO of Atriva Therapeutics, a 2015 startup, explains to Mike Ward, head of pharma...